| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 6.170 | 18.517 | 29.160 | 22.563 | 34.819 | 20.712 | 31.922 | 50.227 | 41.725 | 35.182 |
| Total Income - EUR | 6.171 | 18.517 | 29.160 | 22.563 | 34.820 | 20.735 | 31.936 | 50.316 | 42.017 | 35.184 |
| Total Expenses - EUR | 1.998 | 7.760 | 14.107 | 17.580 | 29.929 | 23.338 | 27.750 | 34.121 | 45.697 | 35.434 |
| Gross Profit/Loss - EUR | 4.173 | 10.757 | 15.054 | 4.984 | 4.891 | -2.603 | 4.186 | 16.194 | -3.680 | -250 |
| Net Profit/Loss - EUR | 3.988 | 10.201 | 14.179 | 4.307 | 3.846 | -3.182 | 3.248 | 14.718 | -4.037 | -343 |
| Employees | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Zazyro Medical Services Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 46 | 9 | 0 | 482 | 14.956 | 10.969 | 7.105 | 3.495 | 2.374 | 1.626 |
| Current Assets | 11.747 | 10.278 | 26.671 | 25.213 | 21.548 | 18.192 | 22.858 | 28.418 | 23.386 | 21.765 |
| Inventories | 2.161 | 1.318 | 3.369 | 4.740 | 6.068 | 6.971 | 5.784 | 9.110 | 9.085 | 7.997 |
| Receivables | 310 | 2.268 | 6.900 | 3.518 | 3.722 | 2.273 | 5.568 | 6.309 | 4.406 | 4.214 |
| Cash | 9.276 | 6.693 | 16.402 | 16.955 | 11.759 | 8.948 | 11.506 | 12.998 | 9.895 | 9.555 |
| Shareholders Funds | 11.703 | 10.255 | 24.260 | 25.633 | 28.983 | 22.771 | 25.513 | 28.144 | 24.021 | 23.544 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 90 | 128 | 2.434 | 306 | 7.746 | 6.662 | 5.037 | 4.381 | 2.331 | 645 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2829 - 2829" | |||||||||
| CAEN Financial Year |
2829
|
|||||||||
Comments - Zazyro Medical Services Srl